|Articles|March 14, 2022
Early Detection of Aggregation in Biotherapeutic Formulations
Author(s)Yokogawa Fluid Imaging Technologies
Submicron Flow Imaging Microscopy with FlowCam Nano enables researchers to detect particulate sources like API aggregation and bacterial contamination that may lead to particle agglomeration if not addressed.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5